Cargando…
Potential antiviral therapies for coronavirus disease 2019 (COVID-19)
The novel coronavirus disease (COVID-2019) caused by severe acute respiratory syndrome coronavirus (called SARS-CoV-2) emerged in China in December 2019 and then spread rapidly to more than 200 countries around the world, including the United States, Spain, Italy, the United Kingdom, Germany, France...
Autores principales: | Singh, Jasdeep, Singhal, Divya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989131/ http://dx.doi.org/10.1016/B978-0-323-90769-9.00036-0 |
Ejemplares similares
-
Recent progress of antiviral therapy for coronavirus disease 2019
por: Zhao, Mengmeng, et al.
Publicado: (2021) -
A Review of Coronavirus Disease-2019 (COVID-19)
por: Singhal, Tanu
Publicado: (2020) -
Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals
por: Mahoney, Monica V., et al.
Publicado: (2022) -
Antiviral Treatment of Coronavirus Disease-2019 Pneumonia
por: Radcliffe, Christopher, et al.
Publicado: (2023) -
Coronavirus Disease 2019–COVID-19
por: Dhama, Kuldeep, et al.
Publicado: (2020)